MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
40.02
+1.69 (4.41%)
Apr 21, 2025, 4:00 PM EDT - Market closed
MLTX Market Cap
MLTX has a market cap or net worth of $2.53 billion as of April 21, 2025. Its market cap has decreased by -12.38% in one year.
Market Cap
2.53B
Enterprise Value
2.09B
1-Year Change
-12.38%
Ranking
Category
Stock Price
$40.02
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $2.53B, an increase of 70,286.86%. That is a compound annual growth rate of 689.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 2.43B | -28.98% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 754.27B |
| UnitedHealth Group | 415.38B |
| Johnson & Johnson | 379.48B |
| AbbVie | 306.02B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 227.16B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |